3rd Clinical Study Involving Liposomal Glutathione

April, 2017

The eleventh study and third clinical study involving Liposomal Glutathione has been published. The study, Restoring cytokine balance in HIV Positive Individuals with Low CD4 T Cell Counts, is to be published in the journal AIDS Research and Human Retroviruses.

Where to Read the Study

The study can read in full here.

PubMed ID: 28398068

Excerpt from Abstract

Supplementation of HIV positive subjects with liposomal glutathione for 3 months, resulted in a notable increase in the levels of IL-12, IL-2, and IFN-γ, with concomitant decrease in the levels of IL-6, IL-10 and free radicals, and stabilization in the levels of TGF-beta, IL-1 and IL-17, compared to their placebo counterparts. Levels of free radicals in CD4+ T cells stabilized while glutathione levels increased in the treatment group. Those in the placebo group showed no significant difference throughout the study. In summary, supplementation with liposomal glutathione in HIV-infected individuals with CD4+ T cell counts below 350 cells/mm3 can help restore redox homeostasis and cytokine balance, therefore aiding the immune system to control opportunistic infections.